Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation
- PMID: 18561945
- PMCID: PMC2670565
- DOI: 10.1016/j.yjmcc.2008.05.004
Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation
Abstract
Stem cell transplantation has emerged as a potential modality in cardiovascular therapeutics due to their inherent characteristics of self-renewal, unlimited capacity for proliferation and ability to cross lineage restrictions and adopt different phenotypes. Constrained by extensive death in the unfriendly milieu of ischemic myocardium, the results of heart cell therapy in experimental animal models as well as clinical studies have been less than optimal. Several factors which play a role in early cell death after engraftment in the ischemic myocardium include: absence of survival factors in the transplanted heart, disruption of cell-cell interaction coupled with loss of survival signals from matrix attachments, insufficient vascular supply and elaboration of inflammatory cytokines resulting from ischemia and/or cell death. This article reviews various signaling pathways involved in triggering highly complex forms of cell death and provides critical appreciation of different novel anti-death strategies developed from the knowledge gained from using an ischemic preconditioning approach. The use of pharmacological preconditioning for up-regulation of pro-survival proteins and cardiogenic markers in the transplanted stem cells will be discussed.
Figures
References
-
- Anversa P, Leri A, Rota M, Hosoda T, Bearzi C, Urbanek K, Urbanek J, Bolli R. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells. 2007;25:589–601. - PubMed
-
- Sanchez A, Garcia-Sancho J. Cardiac repair by stem cells. Cell Death Differ. 2007;14:1258–1261. - PubMed
-
- Invernici G, Cristini S, Madeddu P, Brock S, Spillmann F, Bernasconi P, Cappelletti C, Calatozzolo C, Fascio U, Bisleri G, Muneretto C, Alessandri G, Parati EA. Human adult skeletal muscle stem cells differentiate into cardiomyocyte phenotype in vitro. Exp Cell Res. 2007 - PubMed
-
- Hagege AA, Marolleau JP, Vilquin JT, Alheritiere A, Peyrard S, Duboc D, Abergel E, Messas E, Mousseaux E, Schwartz K, Desnos M, Menasche P. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation. 2006;114:I108–I113. - PubMed
-
- Watanabe E, Smith DM, Jr, Delcarpio JB, Sun J, Smart FW, Van Meter CH, Jr, Claycomb WC. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant. 1998;7:239–246. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
